HPN Holdings, Inc. (KICK)

CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 1997	FY 1996	FY 1995
Period Ending	Sep 30, 1998	Dec 31, 1997	Dec 31, 1996	Dec 31, 1995
Cash & Equivalents	0.57	1.81	1.33	-
Short-Term Investments	0.17	0.19	-	-
Cash & Short-Term Investments	0.74	2	1.33	-
Cash Growth	-65.18%	50.08%	-	-
Accounts Receivable	0.07	0.01	0.08	-
Other Receivables	-	0.01	-	-
Receivables	0.07	0.13	0.15	-
Inventory	0.59	0.01	0.04	-
Prepaid Expenses	0.02	0.01	0.02	-
Restricted Cash	0	0	1.13	-
Total Current Assets	1.42	2.16	2.67	-
Property, Plant & Equipment	0.1	0.11	0.13	-
Long-Term Investments	-	-	1.21	-
Other Long-Term Assets	0.07	0.05	0.04	-
Total Assets	1.91	2.41	4.25	-
Accounts Payable	0.26	0.16	0.18	-
Current Unearned Revenue	0.13	0.19	0.29	-
Total Current Liabilities	0.39	0.35	0.46	-
Long-Term Unearned Revenue	0.06	0.07	0.07	-
Total Liabilities	0.45	0.42	0.53	-
Common Stock	0	0	0	-
Additional Paid-In Capital	8.24	8.24	8.28	-
Retained Earnings	-6.77	-6.24	-4.56	-
Comprehensive Income & Other	-0.01	-0.01	-	-
Shareholders' Equity	1.46	1.99	3.72	-
Total Liabilities & Equity	1.91	2.41	4.25	-
Net Cash (Debt)	0.74	2	1.33	-
Net Cash Growth	-65.18%	50.08%	-	-
Net Cash Per Share	23.46	63.84	122.98	-
Filing Date Shares Outstanding	0.04	0.04	0.02	0.01
Total Common Shares Outstanding	0.04	0.04	0.02	0.01
Working Capital	1.03	1.8	2.21	-
Book Value Per Share	35.93	48.93	179.61	-
Tangible Book Value	1.46	1.99	3.72	-
Tangible Book Value Per Share	35.93	48.93	179.61	-
Buildings	-	0.1	-	-
Machinery	0.19	0.18	-	-
Leasehold Improvements	0.1	0.1	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.